E-LIB Suche - Ergebnisse für: Forshee, Richard A.

1

Data quality and timeliness analysis for post-vaccination a..:

Deady, Matthew ; Duncan, Ray ; Jones, Lance D....
Frontiers in Public Health. 12 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

Effectiveness of BNT162b2 COVID-19 primary series vaccinati..:

Ogilvie, Rachel P. ; Layton, J. Bradley ; Lloyd, Patricia C....
BMC Pediatrics. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

Modeling US blood donor deferrals under a policy of individ..:

Whitaker, Barbee I. ; Huang, Yin ; Gubernot, Diane...
Transfusion. , 2024

Link: https://doi.org/10.1111/..

4

Assessment of potential adverse events following the 2022–2..:

Shi, Xiangyu Chianti ; Gruber, Joann F. ; Ondari, Michelle...
Vaccine. 42 (2024) 15 - p. 3486-3492 , 2024

Link: https://doi.org/10.1016/..

5

Overview of U.S. COVID-19 vaccine safety surveillance syste..:

Gee, Julianne ; Shimabukuro, Tom T. ; Su, John R....
Vaccine. , 2024

Link: https://doi.org/10.1016/..

6

Effectiveness of monovalent COVID-19 booster/additional vac..:

Layton, J. Bradley ; Peetluk, Lauren ; Wong, Hui Lee...
Vaccine: X. 16 (2024) - p. 100447 , 2024

Link: https://doi.org/10.1016/..

7

Real-world Effectiveness of mRNA COVID-19 Vaccines Among US..:

Lu, Yun ; Lindaas, Arnstein ; Matuska, Kathryn...
Open Forum Infectious Diseases. 11 (2024) 3 - p. , 2024

Link: https://doi.org/10.1093/..

8

Incidence rates of thrombosis with thrombocytopenia syndrom..:

Lloyd, Patricia C. ; Lufkin, Bradley ; Moll, Keran...
Vaccine. 42 (2024) 8 - p. 2004-2010 , 2024

Link: https://doi.org/10.1016/..

9

Evaluation of potential adverse events following COVID-19 m..:

Shoaibi, Azadeh ; Lloyd, Patricia C. ; Wong, Hui-Lee...
Vaccine. 41 (2023) 32 - p. 4666-4678 , 2023

Link: https://doi.org/10.1016/..

10

A Retrospective Review of Center for Biologics Evaluation a..:

Mutanga, Jane Namangolwa ; Nukala, Ujwani ; Rodriguez Messan, Marisabel...
The AAPS Journal. 25 (2023) 1 - p. , 2023

Link: https://doi.org/10.1208/..

11

Benefit-risk assessment of Covid-19 vaccine, MRNA (MRNA-127..:

Yogurtcu, Osman N. ; Funk, Patrick R. ; Forshee, Richard A....
Vaccine: X. 14 (2023) - p. 100325 , 2023

Link: https://doi.org/10.1016/..

12

Surveillance of COVID-19 vaccine safety among elderly perso..:

Wong, Hui-Lee ; Tworkoski, Ellen ; Ke Zhou, Cindy...
Vaccine. 41 (2023) 2 - p. 532-539 , 2023

Link: https://doi.org/10.1016/..

13

Risk of Severe COVID-19 in Prevalent Users of Alpha-1 Adren..:

Graham, David J. ; Izurieta, Hector S. ; Zhang, Di...
The American Journal of Medicine. 136 (2023) 10 - p. 1018-1025.e3 , 2023

Link: https://doi.org/10.1016/..

14

Evaluation of association of anti-PEG antibodies with anaph..:

Zhou, Zhao-Hua ; Cortese, Margaret M. ; Fang, Jia-Long...
Vaccine. 41 (2023) 28 - p. 4183-4189 , 2023

Link: https://doi.org/10.1016/..

15

When can real‐world data generate real‐world evidence?:

Rahman, Motiur ; Dal Pan, Gerald ; Stein, Peter...
Pharmacoepidemiology and Drug Safety. 33 (2023) 1 - p. , 2023

Link: https://doi.org/10.1002/..